Pō a Ao Healing Sanctuary

01 · Understanding the medicine

What is Ayahuasca?

Ayahuasca is a psychoactive botanical brew traditionally made from Banisteriopsis caapi and a DMT-containing plant such as Psychotria viridis. Indigenous peoples of the Amazon have used related brews in healing, spiritual, and community life for generations; Brazilian syncretic churches later developed their own ritual traditions. In contemporary research, ayahuasca is being studied—not prescribed—as a possible aid for depression and other conditions. A small randomized, placebo-controlled trial in adults with treatment-resistant, unipolar depression found rapid symptom improvement after one supervised session, but its sample was small, follow-up was brief, and participants with bipolar disorder, psychotic disorders, significant medical illness, substance misuse, and suicidality were excluded 1. This is promising but cannot establish effectiveness or safety for the general public, and it is not personal treatment advice.

02 · The science

How it works

DMT is a serotonergic psychedelic that also acts at sigma-1 receptors; the harmala alkaloids in B. caapi reversibly inhibit monoamine oxidase, allowing orally consumed DMT to become active. Together they can produce intense changes in perception, emotion, cognition, time, and sense of self, commonly lasting several hours [1, 2]. Human findings are compatible with acute changes in brain systems involved in mood and self-processing, but the full mechanism—and whether biological effects explain longer-term outcomes—remains unsettled. Research on ayahuasca is not interchangeable with research on isolated DMT or other psychedelics.

03 · Hope, with context

What researchers are exploring

Potential benefit is not a promised outcome. The study population, support, setting, and evidence quality all matter.

Depressive symptoms

The controlled trial reported greater short-term reduction in depression ratings than placebo in carefully screened adults with treatment-resistant unipolar depression. Earlier open-label work also suggested improvement, but expectancy, setting, and regression to the mean are difficult to separate from drug effects 1.

Early clinical signal; replication with larger samples, active/placebo controls, longer follow-up, and diverse populations is needed.

Source 1 Source 2

Psychological reflection and wellbeing

Observational studies describe associations between ayahuasca participation and wellbeing, mindfulness, or changes in meaning-making. These findings may reflect ceremony, community, intention, and integration as well as pharmacology; they do not prove that ayahuasca treats a disorder 2.

Low-certainty observational evidence; self-selection and cultural context substantially limit causal conclusions.

Source 2 Source 3

Research into substance-use disorders

NIDA identifies psychedelics as an active research area, including investigation of possible therapeutic applications in medical settings. Ayahuasca-specific evidence remains preliminary, and it should not be represented as a proven treatment for addiction 3.

Investigational; no established ayahuasca indication or treatment protocol.

Source 3

04 · Informed decisions

Safety & medication interactions

Do not start, stop, combine, or taper medicines based on this page. Discuss your complete medication list and health history with your prescriber or pharmacist.

Acute cardiovascular and physical effects

Nausea, vomiting, diarrhea, dizziness, agitation, increased heart rate, and elevated blood pressure can occur. DMT toxicity reports include seizures, loss of coordination, coma, and respiratory arrest; serious events are uncommon in screened research settings but real-world preparations and health conditions vary [2, 4].

Source 2 Source 4

Psychiatric destabilization

Intense fear, panic, confusion, or dysphoria may occur. People with personal or family histories of mania, bipolar disorder, or psychotic disorders were typically excluded from trials; psychedelic exposure may worsen vulnerability or precipitate persistent symptoms in some people. Seek urgent help for dangerous behavior, severe agitation, or loss of contact with reality [1, 3].

Source 1 Source 3

Pregnancy, medical vulnerability, and uncertain contents

Animal studies of higher-dose preparations or isolated harmala alkaloids found potential developmental toxicity, though animal findings do not directly predict human risk. Pregnancy, cardiovascular or neurologic illness, and unknown-strength or contaminated brews require particular caution [2, 3].

Source 2 Source 3

Safety and consent in ceremonial settings

Unregulated settings may lack screening, emergency planning, reliable identification of ingredients, safeguarding, or meaningful consent. Power imbalances and cultural appropriation can create harms separate from pharmacology.

Source 2 Source 3

Interaction considerations

Harmala alkaloids inhibit monoamine oxidase, so combinations with serotonergic, sympathomimetic, stimulant, or other psychoactive medicines can produce unpredictable or dangerous effects, including severe blood-pressure changes, agitation, seizures, or serotonin toxicity. Evidence is incomplete and product composition varies. Do not stop or alter prescribed medicines based on this page; ask a qualified clinician or pharmacist who can review the complete medication, supplement, and health history.

Explore the Safety Center

05 · The wider story

History, culture & legal context

Ayahuasca is not one uniform product or practice. Indigenous Amazonian traditions are living knowledge systems with distinct languages, ethics, songs, leadership, and responsibilities; Brazilian churches and newer retreat settings are different contexts. Cultural and spiritual meaning should not be collapsed into a clinical claim, and clinical research should not be used to authorize extraction, commercialization, or speaking for Indigenous communities.

Legal context

Legal status varies by country, state, and religious or ceremonial facts. In the United States, DMT is controlled in Schedule I and has no approved medical use according to the DEA 4; ayahuasca may therefore present serious legal risk, although litigation and limited religious protections are fact-specific. Brazil recognizes ritual use in a particular regulatory history, but laws change. Check current official law where you are; legality is not evidence of safety or efficacy.

06 · Beyond the experience

Preparation & integration

Before

There is no established public medical preparation, dose, or combination protocol. In legitimate research, trained teams use eligibility screening, informed consent, measured study material, monitoring, and emergency procedures. Anyone considering participation should verify voluntary consent, boundaries, safeguarding, ingredient transparency, emergency access, and respect for local and Indigenous governance; this is not a recommendation to use ayahuasca.

After

Research protocols generally include support before, during, and after the session, but no universally validated integration model exists. Reflective practices, trusted support, and prompt professional help for persisting anxiety, insomnia, mood elevation, confusion, or unusual perceptions may be appropriate. Integration cannot guarantee benefit or prevent harm.

Questions to bring to your care team

What does the evidence actually show for this condition, population, and time horizon—and what remains unknown?
How would medical history, mental-health history, pregnancy status, and every medicine or supplement change the risk assessment?
Who is responsible for consent, safeguarding, emergency care, confidentiality, and culturally respectful practice?

Preparation guide →Integration support →

07 · Follow the evidence

Sources & further reading

Read the original work. Publication is not endorsement, and a source check is not independent clinical review.